Markets

Radius Health (RDUS) Looks Good: Stock Rises 6.5% - Tale of the Tape

Radius Health, Inc. ( RDUS ) was a big mover last session with its shares rising roughly 7% on the day. The upside was owing to the company's announcement of positive top line data for its osteoporotic fracture candidate from the first six months of the ACTIVExtend trial and 25-month combined data from ACTIVE and ACTIVExtend. This development led to far more shares changing hands yesterday than in a normal session. The move breaks the recent trend of the company as the stock is now trading above the past one month's volatile price range of $46.63 to $49.43.

This biopharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate has also remained unchanged over the same period. Yesterday's rally is encouraging though, so make sure to keep a close watch on this firm in the near future.

Radius Health currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

A better-ranked stock in the Med-Drugs industry is Valeant Pharmaceuticals International, Inc. ( VRX ) with a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

RADIUS HEALTH (RDUS): Free Stock Analysis Report

VALEANT PHARMA (VRX): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

RDUS

Other Topics

Investing Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More